Replies to post #340857 on Anavex Life Sciences Corp (AVXL)

[Investor2014]

Yes the natural continuation of the analogy.

How can Missling be repeatedly wrong for over a year of moving the AVATAR goal post.

Before that the 3 trials starting goal post by a couple of years.

That’s more hit and miss than ‘just regular biotech’.

Of course all will be forgiven if the AVATER and then EXCELLENCE news turn out absolutely great.

These missed expectations can only raise suspicions and hence taking profits along the way in this biotech game is imo a must.